Thank you, Daniel and thank you all for joining us this morning. We had a really terrific quarter, and we expect a strong finish to fiscal 2023. This morning, I'm going to be a bit more prescriptive than usual as it relates to how we think about our business trajectory one year out. We realized that between adding the Pet business and our outsized foodservice performance, we are making for a challenging model. So, let's start with our Pet acquisition. You can infer from PCB's reported margins that Pet Food margin realization is exceeding expectations. In fact, contribution has well exceeded our underwriting case. There are three reasons. First, changes in factory leadership and behaviors within our factories have enabled us to improve service levels and rebuild customer inventories. Second, our G&A assumptions are proving to be conservative. And last, we have not yet begun to invest in brand rehabilitation. While we are not going to give specific guidance, it is fair to say our expectations for its contribution have increased in the short-term and meaningfully more so once we move past full integration and synergy realization. Recall our three-tiered approach to evaluating this acquisition. We said if we can increase margins, it will prove to be a good investment. Our margin opportunity is greater than expected and already starting to hit the P&L. The second tier was brand rehabilitation. In 2024, we will start to reinvest some of the margin upside and seek to revitalize these brands. That was investment success, Tier 2. And finally, we are building this over the long-term as a platform for inorganic growth. Related to inorganic growth, I'm very proud of this team's integration efforts. Going back all the way to MOM brands, TreeHouse Private label, Peter Pan and now Pet, we have developed a real proficiency at delivering sustainable synergies. The other contributor to outsized results this quarter was foodservice. The business continues its terrific performance. Ignoring the outsized performance, baseline is performing extremely well. Volumes grew 3% and mix continues to shift towards higher value-added products. In tandem, the volume growth and favorable mix produced a sustainably higher level of EBITDA than pre-COVID. We estimate this to be approximately $90 million per quarter prior to the impact of ready-to-drink protein shake manufacturing, which will come online in the first quarter of fiscal 2024. On top of a strong baseline, we delivered outsized performance. Matt will provide some detail on its drivers and the trajectory to normalization. Last night, we raised our adjusted EBITDA guidance to $1.18 billion to $1.2 billion. Back to my comment about helping you model by being more prescriptive, while our FY 2024 planning is in the preliminary stages, we expect to show modest EBITDA growth next year with our current guidance as the baseline. Further, we expect to be well positioned for FY 2025 as we realize synergies from the Pet acquisition, continue to improve supply chains and make incremental investments in marketing. The step-up in marketing is not limited to pet. We are stepping up marketing spend across categories, including US and UK cereal and the Bob Evans brand. Last, I want to be as clear as possible that in anticipating growth next year, we are including seven more months of Pet results and normalizing food service. Those are the significant offsets. Hopefully, the outlook for 2023 and these preliminary comments around 2024 give you the ability to appropriately factor recent M&A and current year performance in your models. Turning to ready-to-eat cereal. There have been questions lately about volume resiliency in the face of 2 years of stack pricing. In fact, category pounds were down 3.9%. We attribute this to lapping Omicron, a shift to away-from-home breakfast consumption and most significantly, the March reduction in SNAP benefits. Omicron and SNAP are non-repeating and as a result, we tend to think of the category as mean reverting to a pre-COVID 0% to 2% decline. We are also seeing a notable shift to value-priced products. Our shipment volumes this quarter declined 5.7%, but half of the volume decline was a result of Peter Pan shipments lapping the temporary market withdrawal of the Jif brand. On a consumption basis, we grew sequential dollar share in Cereal to 19.9%, and Peter Pan has grown half a share point on a two-year basis. Refrigerated Retail had a mixed quarter. Supply chains have markedly improved over last year and have enabled product continuity and margin expansion. On the negative side, we continue to see pressure from private label impacting volumes, and we are responding with our first television advertising in two years. We fully expect to see this brand resume its growth as we drive incremental households and expand distribution, both supported by reengaged marketing. Weetabix is in a tough macro environment with UK consumers facing food, energy and housing inflation, well ahead of the US. The business is being well managed, and we are investing in the brand for the long-term. In fact, against the backdrop of strong company-wide quarter, we are increasing marketing and Weetabix entered 2024 in stronger shape. In terms of capital allocation, we continue to weigh M&A, deleveraging and share buybacks against each other. We have been aggressive purchasers lately since the announcement of our Pet acquisition, we have open market repurchased approximately 60% of the amount of shares that we issued to J.M. Smucker, all while keeping our leverage ratio on a downward trajectory. In closing, we remain quite confident in our recent portfolio moves, and we continue to see momentum building in our business. With that, I will turn the call over to Matt.